{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:09Z","timestamp":1791348789794,"version":"4.3.1"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"F.B."},{"name":"K.B."},{"name":"G.S.L.","award":["2011-RARE-013-01"],"award-info":[{"award-number":["2011-RARE-013-01"]}]},{"DOI":"10.13039\/501100011879","name":"LERMIT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CEREDIH"},{"name":"French National Reference Center for Primary Immune Deficiencies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>GATA2 deficiency\u2014formerly described as MonoMAC syndrome; dendritic cells, monocytes, B cells, and natural killer cell deficiency; familial myelodysplastic syndrome\/acute myeloid leukemia; or Emberger syndrome\u2014encompasses a range of hematologic and nonhematologic anomalies, mainly characterized by monocytopenia, B lymphopenia, natural killer cell cytopenia, neutropenia, immunodeficiency, and a high risk of developing acute myeloid leukemia. Herein, we present 7 patients with GATA2 deficiency recruited into the French Severe Chronic Neutropenia Registry, which enrolls patients with all kinds of congenital neutropenia. We performed extended immunophenotyping of their whole blood lymphocyte populations, together with the analysis of their chemotactic responses. Lymphopenia was recorded for B and CD4+ T cells in 6 patients. Although only 3 patients displayed natural killer cell cytopenia, the CD56bright natural killer subpopulation was nearly absent in all 7 patients. Natural killer cells from 6 patients showed decreased CXCL12\/CXCR4-dependent chemotaxis, whereas other lymphocytes, and most significantly B lymphocytes, displayed enhanced CXCL12-induced chemotaxis compared with healthy volunteers. Surface expression of CXCR4 was significantly diminished in the patients\u2019 natural killer cells, although the total expression of the receptor was found to be equivalent to that of natural killer cells from healthy individual controls. Together, these data reveal that GATA2 deficiency is associated with impaired membrane expression and chemotactic dysfunctions of CXCR4. These dysfunctions may contribute to the physiopathology of this deficiency by affecting the normal distribution of lymphocytes and thus potentially affecting the susceptibility of patients to associated infections.<\/jats:p>","DOI":"10.1189\/jlb.5ma0815-388r","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T03:33:28Z","timestamp":1451360008000},"page":"1065-1076","source":"Crossref","is-referenced-by-count":37,"title":["Altered chemotactic response to CXCL12 in patients carrying <i>GATA2<\/i> mutations"],"prefix":"10.1093","volume":"99","author":[{"given":"Anna","family":"Maciejewski-Duval","sequence":"first","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriane","family":"Meuris","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bignon","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Aknin","sequence":"additional","affiliation":[{"name":"US31-UMS3679 -Plateforme PLAIMMO, Institut Paris-Saclay d\u2019Innovation Th\u00e9rapeutique (IPSIT), INSERM, CNRS, Universit\u00e9 Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Balabanian","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[{"name":"G\u00e9n\u00e9tique et Anomalies du D\u00e9veloppement, EA4271, Universit\u00e9 de Bourgogne, Dijon, France and FHU TRANSLAD, D\u00e9partement de G\u00e9n\u00e9tique, CHU Dijon , Dijon , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Pasquet","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019H\u00e9matologie du Centre Hospitalier Universitaire Toulouse Purpan and INSERM, CRCT, IUCT-Oncopole , Toulouse , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Barlogis","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie P\u00e9diatrique, Assistance Publique, H\u00f4pitaux de Marseille, H\u00f4pital Timone Enfants , Marseille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fieschi","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Immunologie Clinique, H\u00f4pital Saint Louis and Universit\u00e9 Denis Diderot , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bellann\u00e9-Chantelot","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux de Paris, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, D\u00e9partement de G\u00e9n\u00e9tique, Universit\u00e9 Pierre et Marie Curie , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Donadieu","sequence":"additional","affiliation":[{"name":"H\u00f4pitaux de Paris, Registre Francais des Neutrop\u00e9nies Chroniques S\u00e9v\u00e8res, Centre de R\u00e9f\u00e9rence des D\u00e9ficits Immunitaires H\u00e9r\u00e9ditaires, Service d\u2019H\u00e9mato-oncologie P\u00e9diatrique H\u00f4pital Trousseau , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Schlecht-Louf","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Marin-Esteban","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Bachelerie","sequence":"additional","affiliation":[{"name":"UMR996 - Inflammation, Chemokines and Immunopathology, Inserm, Univ Paris-Sud, Universit\u00e9 Paris-Saclay , Clamart , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"2023013012484776000_B1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2011.048355","article-title":"Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome","volume":"96","author":"Bigley","year":"2011","journal-title":"Haematologica"},{"key":"2023013012484776000_B2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"2023013012484776000_B3","first-page":"237","article-title":"Deaf-mutism, lymphedema of the lower limbs and hematological abnormalities (acute leukemia, cytopenia) with autosomal dominant transmission [in French]","volume":"27","author":"Emberger","year":"1979","journal-title":"J. Genet. Hum."},{"key":"2023013012484776000_B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"2023013012484776000_B5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat. Genet."},{"key":"2023013012484776000_B6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood.V122.21.1520.1520","article-title":"GATA2 mutations in pediatric myelodysplastic syndromes and bone marrow failure","volume":"122","author":"Hofmann","year":"2013","journal-title":"Blood"},{"key":"2023013012484776000_B7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"2023013012484776000_B8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat. Genet."},{"key":"2023013012484776000_B9","volume-title":"54th ASH Annual Meeting and Exposition","author":"Townsley","year":"2012"},{"key":"2023013012484776000_B10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"2023013012484776000_B11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","article-title":"High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","volume":"121","author":"Pasquet","year":"2013","journal-title":"Blood"},{"key":"2023013012484776000_B12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"2023013012484776000_B13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"2023013012484776000_B14","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"2023013012484776000_B15","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1182\/blood-2011-06-362574","article-title":"Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking","volume":"118","author":"Mayol","year":"2011","journal-title":"Blood"},{"key":"2023013012484776000_B16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1600-065X.2003.00068.x","article-title":"Egress: a receptor-regulated step in lymphocyte trafficking","volume":"195","author":"Rosen","year":"2003","journal-title":"Immunol. Rev."},{"key":"2023013012484776000_B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? the example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"2023013012484776000_B18","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2002-10-3293","article-title":"Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD\/SCID mice","volume":"102","author":"Beider","year":"2003","journal-title":"Blood"},{"key":"2023013012484776000_B19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ni1523","article-title":"Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor","volume":"8","author":"Walzer","year":"2007","journal-title":"Nat. Immunol."},{"key":"2023013012484776000_B20","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"key":"2023013012484776000_B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat. Genet."},{"key":"2023013012484776000_B22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1172-7-71","article-title":"Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry","volume":"7","author":"Beaussant Cohen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"2023013012484776000_B23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/156652411795677963","article-title":"Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome","volume":"11","author":"Dotta","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"2023013012484776000_B24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","article-title":"A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia","volume":"89","author":"Wetzler","year":"1990","journal-title":"Am. J. Med."},{"key":"2023013012484776000_B25","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1182\/blood-2012-01-403378","article-title":"Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice","volume":"119","author":"Balabanian","year":"2012","journal-title":"Blood"},{"key":"2023013012484776000_B26","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2011-07-368084","article-title":"The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome","volume":"118","author":"McDermott","year":"2011","journal-title":"Blood"},{"key":"2023013012484776000_B27","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2013-09-527226","article-title":"A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor","volume":"123","author":"McDermott","year":"2014","journal-title":"Blood"},{"key":"2023013012484776000_B28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1469-0691.2010.03187.x","article-title":"Two cases of disseminated Mycobacterium avium infection associated with a new immunodeficiency syndrome related to CXCR4 dysfunctions","volume":"17","author":"Doncker","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"2023013012484776000_B29","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"2023013012484776000_B30","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2015.01.014","article-title":"Chromothriptic cure of WHIM syndrome","volume":"160","author":"McDermott","year":"2015","journal-title":"Cell"},{"key":"2023013012484776000_B31","volume-title":"J. Invest. Dermatol.","author":"Meuris","year":"2015"},{"key":"2023013012484776000_B32","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.32857","article-title":"Detection of an interstitial 3q21.1-q21.3 deletion in a child with multiple congenital abnormalities, mental retardation, pancytopenia, and myelodysplasia","volume":"149A","author":"Callier","year":"2009","journal-title":"Am. J. Med. Genet. A."},{"key":"2023013012484776000_B33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"2023013012484776000_B34","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2014-08-598565","article-title":"DUSP4-mediated accelerated T-cell senescence in idiopathic CD4 lymphopenia","volume":"125","author":"Bignon","year":"2015","journal-title":"Blood"},{"key":"2023013012484776000_B35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"2023013012484776000_B36","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J. Exp. Med."},{"key":"2023013012484776000_B37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.1300111","article-title":"Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood","volume":"191","author":"Chan","year":"2013","journal-title":"J. Immunol."},{"key":"2023013012484776000_B38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bbmt.2015.05.025","article-title":"Adaptive natural killer cell and killer cell immunoglobulin-like receptor-expressing t cell responses are induced by cytomegalovirus and are associated with protection against cytomegalovirus reactivation after allogeneic donor hematopoietic cell transplantation","volume":"21","author":"Davis","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2023013012484776000_B39","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","article-title":"CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet\u2019s uveitis","volume":"175","author":"Ahn","year":"2005","journal-title":"J. Immunol."},{"key":"2023013012484776000_B40","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2003-06-2125","article-title":"Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells","volume":"103","author":"Verneris","year":"2004","journal-title":"Blood"},{"key":"2023013012484776000_B41","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.145.10.3194","article-title":"Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis","volume":"145","author":"Robertson","year":"1990","journal-title":"J. Immunol."},{"key":"2023013012484776000_B42","first-page":"9","article-title":"Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer","volume":"5","author":"Robertson","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"2023013012484776000_B43","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4049\/jimmunol.164.3.1148","article-title":"Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression","volume":"164","author":"Pittet","year":"2000","journal-title":"J. Immunol."},{"key":"2023013012484776000_B44","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"key":"2023013012484776000_B45","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.180.8.5327","article-title":"Effector memory \u03b1\u03b2 T lymphocytes can express Fc\u03b3RIIIa and mediate antibody-dependent cellular cytotoxicity","volume":"180","author":"Cl\u00e9menceau","year":"2008","journal-title":"J. Immunol."},{"key":"2023013012484776000_B46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1309\/AJCP1T0JPBLSLAQF","article-title":"Expansion of a clonal CD8+CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma","volume":"139","author":"Wolniak","year":"2013","journal-title":"Am. J. Clin. Pathol."},{"key":"2023013012484776000_B47","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.4049\/jimmunol.154.11.6182","article-title":"Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset","volume":"154","author":"Morley","year":"1995","journal-title":"J. Immunol."},{"key":"2023013012484776000_B48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1365-2958.2007.05865.x","article-title":"A processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune response","volume":"65","author":"Klement","year":"2007","journal-title":"Mol. Microbiol."},{"key":"2023013012484776000_B49","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.03.062","article-title":"Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes","volume":"157","author":"Walch","year":"2014","journal-title":"Cell"},{"key":"2023013012484776000_B50","doi-asserted-by":"crossref","first-page":"e40959","DOI":"10.1371\/journal.pone.0040959","article-title":"Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells","volume":"7","author":"Fujiwara","year":"2012","journal-title":"PLoS One"},{"key":"2023013012484776000_B51","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.113.089714","article-title":"\u03b2-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma","volume":"85","author":"Clift","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"2023013012484776000_B52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/embj.201386022","article-title":"\u03b2-Arrestin-1 mediates the TCR-triggered re-routing of distal receptors to the immunological synapse by a PKC-mediated mechanism","volume":"33","author":"Fern\u00e1ndez-Arenas","year":"2014","journal-title":"EMBO J."},{"key":"2023013012484776000_B53","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2014-09-601807","article-title":"Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors","volume":"125","author":"G\u00f3mez-Mout\u00f3n","year":"2015","journal-title":"Blood"},{"key":"2023013012484776000_B54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exphem.2006.04.002","article-title":"Mutual, reciprocal SDF-1\/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD\/SCID chimeric mice","volume":"34","author":"Dar","year":"2006","journal-title":"Exp. Hematol."},{"key":"2023013012484776000_B55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clim.2013.04.003","article-title":"Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10\/CXCR3 and SDF-1\/CXCR4 axis produce IFN-\u03b3 in response to Bacille Calmette Guerin","volume":"148","author":"Fu","year":"2013","journal-title":"Clin. Immunol."},{"key":"2023013012484776000_B56","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.4049\/jimmunol.171.6.2889","article-title":"Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12","volume":"171","author":"Inngjerdingen","year":"2003","journal-title":"J. Immunol."},{"key":"2023013012484776000_B57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cellimm.2004.10.001","article-title":"IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells","volume":"230","author":"Sechler","year":"2004","journal-title":"Cell. Immunol."},{"key":"2023013012484776000_B58","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00262-011-1067-6","article-title":"Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function","volume":"60","author":"Moustaki","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"2023013012484776000_B59","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bj\u00f6rkstr\u00f6m","year":"2010","journal-title":"Blood"},{"key":"2023013012484776000_B60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front. Immunol."},{"key":"2023013012484776000_B61","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verg\u00e8s","year":"2010","journal-title":"Blood"},{"key":"2023013012484776000_B62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1023283719877","article-title":"Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging","volume":"18","author":"McNerlan","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"2023013012484776000_B63","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eji.201141826","article-title":"CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients","volume":"42","author":"B\u00e9ziat","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"2023013012484776000_B64","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2023013012484776000_B65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/leu.2014.161","article-title":"Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes","volume":"29","author":"Della Porta","year":"2015","journal-title":"Leukemia"},{"key":"2023013012484776000_B66","first-page":"1074","article-title":"Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling","volume":"118","author":"Balabanian","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2023013012484776000_B67","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"key":"2023013012484776000_B68","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.4049\/jimmunol.177.11.7833","article-title":"Evidence for NK cell subsets based on chemokine receptor expression","volume":"177","author":"Berahovich","year":"2006","journal-title":"J. Immunol."},{"key":"2023013012484776000_B69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.imbio.2005.12.003","article-title":"Differences in CXCR4-mediated signaling in B cells","volume":"211","author":"Palmesino","year":"2006","journal-title":"Immunobiology"},{"key":"2023013012484776000_B70","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/CJI.0b013e31822bc3d0","article-title":"Functional consequences of human lymphocyte cryopreservation: implications for subsequent interactions of cells with endothelium","volume":"34","author":"Faint","year":"2011","journal-title":"J. Immunother."},{"key":"2023013012484776000_B71","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.chom.2010.11.006","article-title":"A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome","volume":"8","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.5MA0815-388R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/99\/6\/1065\/48178955\/jlb1065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/99\/6\/1065\/48178955\/jlb1065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:36:52Z","timestamp":1677505012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/99\/6\/1065\/6936366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,12,28]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.5ma0815-388r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,6]]},"published":{"date-parts":[[2015,12,28]]}}}